Clinical Trial Update: To Evaluate OBI-833/OBI-821 in Patients With Locally Advanced, Globo H-Positive Esophageal Cancer for Recurrence [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating OBI-833/OBI-821 in locally advanced Globo H-positive esophageal cancer for recurrence is ongoing with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Drugs mentioned

• OBI-833/OBI-821

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Esophageal Cancer | Phase 2 | Status: UNKNOWN